Voyager, the health and wellness company established to supply Cannabidiol (CBD) and hemp seed oil products, has announced the company’s intention to seek admission to trading on the Aquis Stock Exchange Growth Market. Admission is expected to occur in Q2-2021.
In February 2021 the company launched a crowdfunding campaign through Seedrs, raising £874,000.
This month Voyager has raised a further £741,000 through a private fundraise, including a commitment of £100,000 from Greencare Capital plc, the Aquis-listed investment company focused on medicinal cannabis and related areas.
Voyager was incorporated in November 2020 as a health and wellness business focused on CBD and hemp seed oil products. The Company’s directors believe that a significant opportunity exists in the CBD market due to the forecast growth and ongoing regulatory changes.
Nick Tulloch, CEO of Voyager, said: “We believe this is a sector with significant growth potential and our focus has been on building our product range alongside a robust approach to assurance and compliance as strong foundations to build the brand and the business. The Voyager team has extensive industry experience and our oversubscribed crowdfunding along with the strong support in our more recent fundraising underlines the significant investor appetite for our approach.
“At the time of our crowdfunding campaign in February 2021, we were clear with investors that our aspirations were to take Voyager onto the public markets when the time was right. The progress made by the business, coupled with strong investor backing, has enabled us to realise these plans far more rapidly than we originally envisaged. We believe that Aquis provides an ideal platform for Voyager to continue to build its profile and provide our investors with liquidity whilst maintaining the Company’s EIS-qualifying status.”